When clinicians contemplate the use of a new predictive technology in their practice, such as a nomogram, there is always a question of whether the new test is beneficial to their own clinical ...
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Researchers have reported that cell free DNA analysis is less effective than sequential screening as primary testing for fetal chromosomal abnormalities. In a study to be presented on Feb. 5 in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results